A detailed history of Ifp Advisors, Inc transactions in Evolus, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 27 shares of EOLS stock, worth $270. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27
Holding current value
$270
% of portfolio
0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$10.45 - $13.76 $282 - $371
27 New
27 $0
Q2 2022

Sep 06, 2022

BUY
$10.22 - $13.94 $9,198 - $12,546
900 New
900 $25,000
Q2 2022

Aug 12, 2022

SELL
$10.22 - $13.94 $9,198 - $12,546
-900 Closed
0 $0
Q1 2022

Sep 06, 2022

SELL
$5.22 - $11.78 $4,698 - $10,602
-900 Reduced 50.0%
900 $10,000
Q3 2021

Oct 06, 2021

SELL
$7.36 - $13.67 $368 - $683
-50 Reduced 2.7%
1,800 $14,000
Q1 2021

Apr 30, 2021

BUY
$3.2 - $16.51 $5,920 - $30,543
1,850 New
1,850 $24,000
Q4 2020

Jan 25, 2021

BUY
$2.92 - $4.84 $0 - $0
0 New
0 $0
Q3 2020

Oct 29, 2020

BUY
$3.03 - $5.48 $0 - $0
0 New
0 $0
Q2 2020

Aug 05, 2020

BUY
$3.53 - $6.17 $0 - $0
0 New
0 $0
Q1 2020

May 12, 2020

BUY
$3.53 - $12.21 $0 - $0
0 New
0 $0
Q4 2019

Jan 17, 2020

SELL
$11.58 - $17.37 $65,913 - $98,870
-5,692 Closed
0 $0
Q3 2019

Nov 07, 2019

SELL
$13.91 - $19.87 $98,329 - $140,461
-7,069 Reduced 55.4%
5,692 $88,000
Q1 2019

May 15, 2019

BUY
$12.43 - $28.91 $53,088 - $123,474
4,271 Added 50.31%
12,761 $286,000
Q4 2018

Jan 23, 2019

BUY
$10.57 - $19.29 $63,314 - $115,547
5,990 Added 239.6%
8,490 $101,000
Q2 2018

Aug 07, 2018

SELL
$6.85 - $38.49 $70,287 - $394,945
-10,261 Reduced 80.41%
2,500 $0
Q1 2016

Jun 03, 2019

BUY
N/A
12,761
12,761 $286,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $561M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.